A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Clinical trial NCT05161481 · TERMINATED

Trial details

NCT number: NCT05161481
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Portal

Start date: 2022-04-27
Primary completion: 2024-05-02
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.